Archive for January, 2012
Monday, January 30th, 2012
Earlier this month Bedford Laboratories updated guidance on its August 2011 recall of Polymyxin B for Injection USP and Vecuronium Bromide for Injection. Since there have been a number of recalls throughout the industry involving glass vials, we posed a few questions regarding the updated guidance. (Note: Bedford Laboratories ...
Posted in Recalls | 1 Comment »
Thursday, January 26th, 2012
"There's no such thing as a sustainable package," Al Iannuzzi recently told me. "Every package has a footprint. But you can make a package greener or more sustainable through continuous improvement."
Iannuzzi has reached this conclusion after working for more than 30 years in the environmental, health, and safety field, once ...
Posted in Sustainability | 1 Comment »
Tuesday, January 24th, 2012
In our daily newsletter today, we shared a report of a substantial payout in a court case involving contaminated propofol vials. A jury had ordered Teva Pharmaceuticals and Baxter Healthcare Corp. to pay $104 million to a 71-year-old patient and his wife after he contracted hepatitis C reportedly after being ...
Posted in Design, Drug Delivery, Hospital, Medical Errors, Safety, vials | No Comments »
Wednesday, January 4th, 2012
In December, Brazil's ANVISA indicated that implementation of Law 11.903/2009 (Serialization / Traceability) is changing. Comments published on ANVISA's Web site imply that the controversial provision for security labels printed by the Brazilian Mint (Casa do Moeda) established in RDC 59 and in subsequent normative instructions will be replaced by ...
Posted in Uncategorized | No Comments »
